These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries. Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749 [TBL] [Abstract][Full Text] [Related]
10. Bioabsorbable scaffold optimization in provisional stenting: insight from optical coherence tomography. Foin N; Ghione M; Mattesini A; Davies JE; Di Mario C Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1149. PubMed ID: 23884966 [No Abstract] [Full Text] [Related]
11. 10-Year optical coherence tomography follow-up of 'full-plastic jacket' with bioresorbable vascular scaffolds. Tarantini G; Putortì F; Nai Fovino L Eur Heart J; 2024 Feb; 45(7):556. PubMed ID: 38104277 [No Abstract] [Full Text] [Related]
12. Culotte Technique With a Bioresorbable Vascular Scaffold: 12 Months' Follow-up. Vera Pernasetti L; Gutiérrez H; Ramos B Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):973-974. PubMed ID: 27085839 [No Abstract] [Full Text] [Related]
13. Vessel Caging Versus Vascular Restoration in the Same Artery: Long-Term Vascular Remodeling and Healing in Response to Overlapping Metal Stent and Bioresorbable Polymer Scaffold. Gongora CA; Shibuya M; Ramzipoor K; Lee C; Cheng Y; McGregor JC; Estrada EA; Granada JF; Kaluza GL JACC Cardiovasc Interv; 2015 Apr; 8(4):631-2. PubMed ID: 25819184 [No Abstract] [Full Text] [Related]
14. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold. Mangiameli A; Ohno Y; Attizzani GF; Capodanno D; Tamburino C JACC Cardiovasc Interv; 2015 Apr; 8(4):633-4. PubMed ID: 25819179 [No Abstract] [Full Text] [Related]
15. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge. Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423 [No Abstract] [Full Text] [Related]
16. Expanded clinical use of everolimus eluting bioresorbable vascular scaffolds for treatment of coronary artery disease. Diletti R; Ishibashi Y; Felix C; Onuma Y; Nakatani S; van Mieghem NM; Regar E; Valgimigli M; de Jaegere PP; van Ditzhuijzen N; Fam JM; Ligthart JMR; Lenzen MJ; Serruys PW; Zijlstra F; Jan van Geuns R Catheter Cardiovasc Interv; 2017 Jul; 90(1):58-69. PubMed ID: 27896897 [TBL] [Abstract][Full Text] [Related]
17. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness. Pichette M; Chevalier F; Généreux P Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768 [TBL] [Abstract][Full Text] [Related]
18. Neointimal coverage of overlapping everolimus-eluting bioresorbable scaffolds: An optical coherence tomography study in native coronary arteries. Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M Int J Cardiol; 2016 Oct; 221():243-5. PubMed ID: 27404683 [No Abstract] [Full Text] [Related]